ASMB Assembly Biosciences Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ASMB

Price (delayed)

$24.17

Market cap

$384.12M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.11

Enterprise value

$355.5M

?
Relative Growth: Rel. Growth: 20
Relative Strength: Rel. Strength: 46
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 25

Assembly Bio is a clinical-stage biotechnology company committed to bringing finite and curative therapies to the 270 million people living with hepatitis B virus (HBV) worldwide. A pioneer in the ...

Highlights
ASMB's EPS has surged by 98% year-on-year and by 80% since the previous quarter
ASMB's quick ratio is up by 27% since the previous quarter
Assembly Biosciences's net income has surged by 84% YoY but it has decreased by 4.3% QoQ
The equity has decreased by 3.9% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.assemblybio.com
Peers: IRWD CPIX

Key stats

What are the main financial stats of ASMB

ASMB stock price

How has the Assembly Biosciences stock price performed over time
Intraday
-1.63%
1 week
-12.84%
1 month
-13.12%
1 year
51.16%
YTD
-28.93%
QTD
-12.9%

Financial performance

How have Assembly Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$84.64M
Net income
-$6.38M
Gross margin
N/A
Net margin
N/A
Assembly Biosciences's net income has surged by 84% YoY but it has decreased by 4.3% QoQ
Assembly Biosciences's operating income has decreased by 10% YoY

Price vs fundamentals

How does ASMB's price correlate with its fundamentals

Growth

What is Assembly Biosciences's growth rate over time

Valuation

What is Assembly Biosciences stock price valuation
P/E
N/A
P/B
1.93
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ASMB's EPS has surged by 98% year-on-year and by 80% since the previous quarter
The price to book (P/B) is 42% lower than the last 4 quarters average of 3.4 but 9% higher than the 5-year quarterly average of 1.8
The equity has decreased by 3.9% from the previous quarter

Efficiency

How efficient is Assembly Biosciences business performance
The return on equity has surged by 97% year-on-year and by 25% since the previous quarter
The ROIC has soared by 95% YoY and by 24% from the previous quarter
The company's return on assets has surged by 92% YoY and by 14% QoQ

Dividends

What is ASMB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ASMB.

Financial health

How did Assembly Biosciences financials performed over time
The total assets has soared by 138% YoY but it has contracted by 9% from the previous quarter
ASMB's total liabilities is down by 49% year-on-year and by 27% since the previous quarter
The company's debt is 99% lower than its equity
The debt to equity has plunged by 91% YoY
The company's debt fell by 18% YoY and by 5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.